Aflac Inc(AFL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 4:53 PM ET (Korea 10/28 05:53)
Full metrics table
| Index | S&P 500 | P/E | 13.07 | EPS (ttm) | 9.33 | Insider Own | 10.91% | Shs Outstand | 502.3M | Perf Week | 1.43% |
| Market Cap | 61.16B | Forward P/E | 16 | EPS next Y | 8.55% | Insider Trans | -2.75% | Shs Float | 446.6M | Perf Month | 7.43% |
| Enterprise Value | - | PEG | 6.61 | EPS next Q | 1.8 | Inst Own | 60.51% | Short Float | 2.25% | Perf Quarter | -5.19% |
| Income | 4.86B | P/S | 3.38 | EPS this Y | -6.21% | Inst Trans | -0.58% | Short Ratio | 5.12 | Perf Half Y | 4.9% |
| Sales | 18.07B | P/B | 2.02 | EPS next 5Y | 2.42% | ROA | 4.05% | Short Interest | 10.07M | Perf YTD | 10.63% |
| Book/sh | 60.35 | P/C | - | EPS past 3/5Y | -0.54% 0.43% | ROE | 16.91% | 52W High | -6.32% ($130.22) | Perf Year | 13.43% |
| Cash/sh | - | P/FCF | 23.1 | Sales past 3/5Y | -3.57% -4.97% | ROIC | 12.69% | 52W Low | 15.71% ($105.43) | Perf 3Y | 59.48% |
| Dividend Est. | $2.45 (2.01%) | EV/EBITDA | - | EPS Y/Y TTM | 110.75% | Gross Margin | - | Volatility(W/M) | 2.02% 1.74% | Perf 5Y | 117.84% |
| Dividend TTM | 2.41 | EV/Sales | - | Sales Y/Y TTM | 13.57% | Oper. Margin | 33.36% | ATR (14) | 2.08 | Perf 10Y | 247.5% |
| Dividend Ex-Date | 2026/8/19 | Quick Ratio | - | EPS Q/Q | 46.68% | Profit Margin | 26.91% | RSI (14) | 63.49 | Recom | 3.28 |
| Dividend Gr. 3/5Y | 13.19% 15.68% | Current Ratio | 1 | Sales Q/Q | -1.03% | SMA20 | 4.4% ($116.85) | Beta | 0.56 | Target Price | $117.33 |
| Payout | 34.04% | Debt/Eq | 0.29 | Earnings | 2026/11/4 | SMA50 | 4.78% ($116.42) | Rel Volume | 0.93 | Prev Close | $120.93 |
| Employees | 12716 | LT Debt/Eq | 0.26 | EPS/Sales Surpr. | -0.8% -0.61% | SMA200 | 5.47% ($115.66) | Avg Volume(3M) | 1.97M | Price | $121.99 |
| IPO | 1974/6/14 | Option/Short | Yes/Yes | Trades | 20258 | Volume | 1,835,695 | Change | 0.88% |
A global insurer focused on supplemental life and health insurance in the Japanese and U.S. markets. Founded in 1955 and headquartered in Columbus, Georgia, the company has established itself as a global leader in cancer insurance, Medicare supplement insurance, and disability income insurance, making it a leading representative stock in the life insurance space.
Over the past 1 year, roughly in the middle
6% below its 1-year high.
Traded about as much as usual. That is 93% of its average volume.
Next earnings report: November 4
8 days to go.
AFL makes money exceptionally well
Of every $100 in sales, $33.36 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -6.2% this year.
Tap to view numbers
However, it looks expensive
For a company earning $100 a year, you would pay $1,307. Peers typically go for $1,204. Compared with its own 5-year average, it is 25% pricier now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +117.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 2.01% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 60.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 18 in the industry
Based on market cap of $61B.
FAQ
What kind of company is AFL?
AFL belongs to the Financial sector and operates in the Insurance - Life industry.
What is the market cap of AFL?
The market cap of AFL is approximately $61.2B, ranking 275 within its sector.
Does AFL pay dividends?
AFL has a dividend yield of approximately 2.01%, with an annual dividend of $2.45.
What is the P/E ratio of AFL?
AFL has a P/E ratio of approximately 13.1x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for AFL?
AFL has recorded a 52-week high of $130.22 and a low of $105.43.
